BR112015009546A2 - compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas - Google Patents

compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas

Info

Publication number
BR112015009546A2
BR112015009546A2 BR112015009546A BR112015009546A BR112015009546A2 BR 112015009546 A2 BR112015009546 A2 BR 112015009546A2 BR 112015009546 A BR112015009546 A BR 112015009546A BR 112015009546 A BR112015009546 A BR 112015009546A BR 112015009546 A2 BR112015009546 A2 BR 112015009546A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical
combinations
compounds
preparation processes
mixtures
Prior art date
Application number
BR112015009546A
Other languages
English (en)
Inventor
Atamany Dmytro
Airiau Etienne
Moreau Francois
Monbrun Jerme
Gerusz Vincent
Henryon Vivien
Original Assignee
Laboratoire Biodim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Biodim filed Critical Laboratoire Biodim
Publication of BR112015009546A2 publication Critical patent/BR112015009546A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emergency Medicine (AREA)
BR112015009546A 2012-10-29 2013-04-28 compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas BR112015009546A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306350.5A EP2725029A1 (en) 2012-10-29 2012-10-29 New antibacterial compounds and biological applications thereof
PCT/EP2013/072526 WO2014067904A1 (en) 2012-10-29 2013-10-28 New antibacterial compounds and biological applications thereof

Publications (1)

Publication Number Publication Date
BR112015009546A2 true BR112015009546A2 (pt) 2017-07-04

Family

ID=47278726

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015009546A BR112015009546A2 (pt) 2012-10-29 2013-04-28 compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas

Country Status (13)

Country Link
US (1) US9975911B2 (pt)
EP (2) EP2725029A1 (pt)
JP (1) JP6389463B2 (pt)
KR (1) KR20150105300A (pt)
CN (1) CN104936966A (pt)
AU (1) AU2013339557A1 (pt)
BR (1) BR112015009546A2 (pt)
CA (1) CA2889503A1 (pt)
CL (1) CL2015000985A1 (pt)
HK (1) HK1211034A1 (pt)
MX (1) MX2015005498A (pt)
RU (1) RU2015120376A (pt)
WO (1) WO2014067904A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101881596B1 (ko) 2008-12-02 2018-07-24 웨이브 라이프 사이언시스 재팬 인코포레이티드 인 원자 변형된 핵산의 합성 방법
SG10201403841QA (en) 2009-07-06 2014-09-26 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
EP2620428B1 (en) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetric auxiliary group
JP6128529B2 (ja) 2011-07-19 2017-05-17 ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． 官能化核酸の合成のための方法
US9598458B2 (en) 2012-07-13 2017-03-21 Wave Life Sciences Japan, Inc. Asymmetric auxiliary group
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
CN108484620A (zh) * 2018-04-26 2018-09-04 福建师范大学泉港石化研究院 一种水溶性罗丹明基Cu2+荧光探针及其合成方法
CN108484619A (zh) * 2018-04-26 2018-09-04 福建师范大学泉港石化研究院 一种罗丹明基Fe3+荧光探针及其制备方法
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
RU2770537C1 (ru) * 2021-09-15 2022-04-18 федеральное государственное автономное образовательное учреждение высшего образования «Казанский (Приволжский) федеральный университет» (ФГАОУ ВО КФУ) Фосфорилсодержащие четвертичные соли аммония с высшими алкильными заместителями, обладающие бактерицидной и фунгицидной активностью

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580899A (en) 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
US4206156A (en) * 1976-07-27 1980-06-03 Fujisawa Pharmaceutical Company, Limited Hydroxyaminohydrocarbonphosphonic acids
JPS5463024A (en) * 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
JPS5562019A (en) * 1978-09-14 1980-05-10 Fujisawa Pharmaceut Co Ltd Antibacterial
US4693742A (en) 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
CA1340588C (en) 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
ID27347A (id) * 1998-07-15 2001-04-05 Hassan Jomaa Senyawa organik fosfor dan manfaatnya
CA2436958A1 (fr) 2001-01-29 2002-08-08 Universite De Geneve Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
FR2872158B1 (fr) 2004-06-28 2006-11-03 Merck Sante Soc Par Actions Si Nouveaux composes diazeniumdiolates, leur procede de preparation et leur utilisation therapeutique
EP1669365A1 (en) 2004-12-03 2006-06-14 Mutabilis SA Method for preparing enzymatic substrate analogs as inhibitors of bacterial heptosyl-transferases
KR20090077914A (ko) 2006-09-11 2009-07-16 쿠리스 인코퍼레이션 항증식제로서의 다작용성 소분자
AU2007301607A1 (en) 2006-09-25 2008-04-03 Mutabilis Sa Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
EP2141164A1 (en) 2008-07-01 2010-01-06 Mutabilis New 1,2,4-triazine derivatives and biological applications thereof
DK2389375T3 (en) * 2009-01-23 2015-08-24 Euro Celtique Sa Hydroxamsyrederivater
WO2011045703A2 (en) 2009-10-13 2011-04-21 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
EP2377853A1 (en) 2010-04-09 2011-10-19 Universite de Rouen 7,11-Methanocycloocta[b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
EP2646451A2 (en) 2010-12-01 2013-10-09 Laboratoire Biodim Heptose derivatives for use in the treatment of bacterial infections
WO2013006444A1 (en) * 2011-07-01 2013-01-10 The George Washington University Compounds for inhibiting 1- deoxy-d-xylulose- 5 - phosphate reductoisomerase

Also Published As

Publication number Publication date
CL2015000985A1 (es) 2016-05-13
US9975911B2 (en) 2018-05-22
RU2015120376A (ru) 2016-12-20
JP6389463B2 (ja) 2018-09-12
HK1211034A1 (en) 2016-05-13
EP2912043B1 (en) 2016-11-30
CN104936966A (zh) 2015-09-23
MX2015005498A (es) 2016-01-08
US20150291636A1 (en) 2015-10-15
KR20150105300A (ko) 2015-09-16
JP2015536928A (ja) 2015-12-24
AU2013339557A1 (en) 2015-04-30
EP2912043A1 (en) 2015-09-02
WO2014067904A1 (en) 2014-05-08
EP2725029A1 (en) 2014-04-30
CA2889503A1 (en) 2014-05-08

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
SMT201600354B (it) Composti di beta-lattame sostituiti da ammidina, loro preparazione ed uso come agenti antibatterici
BR112015009546A2 (pt) compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas
BR112014029115A2 (pt) composto, composição farmacêutica, e, uso de um composto ou composição
BR112015002738A2 (pt) composto , e , composição farmacêutica
BR112014027477A2 (pt) métodos de processamento de materiais lingnocelulósicos.
DK3181122T3 (da) Farmaceutisk dasatinib-sammensætning
BR112015003376A2 (pt) composto ou sal farmaceuticamente aceitável do mesmo , composição farmacêutica e usos de quantidade eficiente
IL242347B (en) Macrocyclic compounds, their preparation and pharmaceutical compositions containing them
IL235767A (en) Preserved pyrolidines, pharmaceuticals containing them and their uses
BR112014032285A2 (pt) materiais ajustáveis
IL237839A0 (en) History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
IL235414A (en) The history of pyrolotriazinone, their preparation and their pharmaceutical preparations
HK1222563A1 (zh) 藥物組合物、製備及其用途
BR112015002824A2 (pt) composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.
DK2897594T3 (da) Farmaceutisk sammensætning
BR112015010797A2 (pt) compostos aniônicos substituídos, e, composição farmacêutica
CL2014003283A1 (es) Formulación farmacéutica.
BR112015010271A2 (pt) produto de comicronização, composição farmacêutica e seus usos
IL238060B (en) 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them
IL246406A0 (en) History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them
BR112013017267A2 (pt) formulação de lipossomas, suspensão e composição farmacêutica
DK3473255T3 (da) Farmaceutisk formulering omfattende ciclesonid
BR112015005627A2 (pt) composto, composição farmacêutica, uso de composto, método de tratamento e invenção.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25B Requested transfer of rights rejected

Owner name: LABORATOIRE BIODIM (FR)

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870160006100 DE 24/02/2016 CONFORME DISPOSTO NO ART. 59 DA LEI 9279 DE 14/05/1996, PELO FATO DO PEDIDO DE PATENTE TER SIDO ARQUIVADO DEFINITIVAMENTE NA RPI 2451 DE 26/12/2017.

Owner name: LABORATOIRE BIODIM (FR)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]